STOCK TITAN

Broker files Form 144 for TXG common stock sale (NASDAQ: TXG)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TXG filed a Form 144 reporting a proposed sale of common stock by Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists restricted stock lots of 3,740 shares dated 11/21/2025 and 3,839 shares dated 08/21/2025.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 notice showing proposed broker-held restricted stock sales.

The filing lists proposed dispositions of common stock held as restricted stock with lot dates 11/21/2025 (3,740 shares) and 08/21/2025 (3,839 shares). This is a notice of intent to sell under resale rules.

Form 144s are procedural disclosures; execution method, timing, and proceeds are governed by applicable resale and broker procedures and are not detailed in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does TXG's Form 144 disclose?

The Form 144 discloses a proposed sale of TXG common stock by a broker. It lists restricted stock lots of 3,740 shares dated 11/21/2025 and 3,839 shares dated 08/21/2025 as the securities to be sold.

Who is the selling party on the TXG Form 144?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the selling intermediary. The entry appears under the broker/seller line associated with the proposed sale of TXG common stock.

Do the TXG filing dates indicate when the shares will be sold?

The dates shown (11/21/2025 and 08/21/2025) are grant or restricted stock dates for the listed lots. The Form 144 excerpt does not provide execution timing or settlement dates for any sale transactions.

How many TXG shares are listed for potential sale in the excerpt?

The excerpt lists two restricted stock lots totaling visible counts of 3,740 shares and 3,839 shares tied to their respective grant dates. The document does not aggregate or show additional holder rows in the provided text.

Does the Form 144 disclose proceeds or pricing for the TXG sale?

The provided excerpt does not include dollar proceeds or pricing information. The filing entries list share counts and dates for restricted stock but do not state sale price or aggregate proceeds.
10X Genomics, Inc.

NASDAQ:TXG

TXG Rankings

TXG Latest News

TXG Latest SEC Filings

TXG Stock Data

2.44B
115.51M
Health Information Services
Laboratory Analytical Instruments
Link
United States
PLEASANTON